Form 4: Charles River Labs Director Trades CRL Stock

Virginia M. Wilson, a Director at Charles River Laboratories International, Inc., reported a transaction involving the acquisition of common stock.

Summary

• Virginia M. Wilson, a Director at Charles River Laboratories International, Inc. (CRL), acquired 1,438 shares of common stock on May 8, 2026, at a price of $177.62 per share.
• Following this transaction, Ms. Wilson beneficially owns 6,349 shares of common stock.
• The acquired shares are part of a restricted stock unit award that vests on May 8, 2027, or the business day prior to the company's next annual shareholder meeting, whichever comes first.

Sentiment

Score: 5

Explanation: StockSavvy.ai views this as a neutral filing, as it reports a standard insider transaction (stock acquisition by a director) without providing new financial performance data or strategic outlook.

Positives

• Director acquisition of company stock can signal confidence in the company's future prospects.
• The acquisition of 1,438 shares by a director indicates continued investment in the company.

Future Outlook

The filing does not contain forward-looking statements or guidance. The vesting schedule for restricted stock units provides a future date for ownership transfer.

Industry Context

StockSavvy.ai notes that insider transactions, such as this Form 4 filing by a director, are closely watched by the market as potential indicators of management's confidence in the company's performance and future prospects within the contract research organization (CRO) and life sciences industry.

Stakeholder Impact

• Shareholders: The acquisition of stock by a director may be viewed positively, potentially signaling confidence in the company's value.
• Management: Reinforces the alignment of management's interests with those of shareholders.

Next Steps

• The restricted stock units will vest on May 8, 2027, or the business day prior to the Company's next annual meeting of shareholders.

Key Dates

Keywords

Charles River Laboratories, CRL, Form 4, Insider Trading, Director Transaction, Common Stock, Restricted Stock Units